Biotech · Public company · South San Francisco, CA, US

Kardigan, Inc.

Ticker KARD · SEC CIK 0002123613

Track this companyFree. Adds Kardigan, Inc. to your Dealase workspace and tells you when its record changes.

Clinical trials54 recruiting or active

Pipeline programs4From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Pipeline4

AtaciguatPhase 3 · Moderate Aortic Valve StenosisClinicalTrials.gov · fetched Nov 12, 2026
danicamtivPhase 3 · Symptomatic Genetic Dilated CardiomyopathyClinicalTrials.gov · fetched Nov 12, 2026
DanicamtivPhase 3 · Symptomatic Genetic Dilated Cardiomyopathy (DCM)ClinicalTrials.gov · fetched Nov 12, 2026
TonlamarsenPhase 2 · HypertensionClinicalTrials.gov · fetched Nov 12, 2026

A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated CardiomyopathyPHASE3 · RECRUITING · started Aug 26, 2026ClinicalTrials.gov NCT07771465 · fetched Nov 12, 2026
Study of Efficacy and Safety of Tonlamarsen in Participants With a Recent Hospitalization and a Concurrent Episode of Acute Severe HypertensionPHASE2 · RECRUITING · started Jun 23, 2026ClinicalTrials.gov NCT07511361 · fetched Nov 12, 2026
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated CardiomyopathyPHASE2_PHASE3 · RECRUITING · started Feb 13, 2026ClinicalTrials.gov NCT07210723 · fetched Nov 12, 2026
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled StudyPHASE2_PHASE3 · RECRUITING · started Jun 27, 2025ClinicalTrials.gov NCT07001800 · fetched Nov 12, 2026
A Study to Investigate Tonlamarsen for the Treatment of Adults With Uncontrolled Hypertension (KARDINAL)PHASE2 · COMPLETED · started Apr 10, 2025ClinicalTrials.gov NCT06864104 · fetched Nov 12, 2026